About Venetoclax
            
            Class: | BCL-2 inhibitor  
Use: | Venetoclax is used for the treatment of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), with or without 17p deletion, and for acute myeloid leukemia (AML) in combination with other agents in adults.  
Adult dose: | For CLL/SLL, the starting dose is 20 mg once daily for 7 days, followed by a weekly ramp-up to 50 mg, 100 mg, 200 mg, and 400 mg once daily. For AML, dosing varies based on combination therapy and patient-specific factors.  
Pe
         
        
            
                
                
                    
                        Drug Class
                    
                    BCL-2 inhibitor
                 
                
                
                    
                        Uses & Indications
                    
                    Venetoclax is used for the treatment of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), with or without 17p deletion, and for acute myeloid leukemia (AML) in combination with other agents in adults.
                 
                
                
                    
                        Storage Requirements
                    
                    Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Keep in original packaging to protect from moisture.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Abbvie Inc., U.S.A
                    
                    
                    Package Size
                    14's (7's Blister x 2)
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 483.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        For CLL/SLL, the starting dose is 20 mg once daily for 7 days, followed by a weekly ramp-up to 50 mg, 100 mg, 200 mg, and 400 mg once daily. For AML, dosing varies based on combination therapy and patient-specific factors.
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy in pediatric patients have not been established.
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include neutropenia, diarrhea, nausea, anemia, upper respiratory tract infection, thrombocytopenia, and fatigue.
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Contraindicated in patients with known hypersensitivity to venetoclax or any of its components. Caution in patients with severe hepatic impairment.
         
        
        
            
                Important Warnings
            
            Risk of tumor lysis syndrome (TLS), which can be life-threatening. Monitor blood counts and renal function closely. Adjust dose for concomitant use with CYP3A inhibitors. Avoid grapefruit products and Seville oranges during treatment.
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.